HK1173493A1 - System for determining unprocessed nd partially processed neurotoxin polypeptide - Google Patents

System for determining unprocessed nd partially processed neurotoxin polypeptide

Info

Publication number
HK1173493A1
HK1173493A1 HK13100603.4A HK13100603A HK1173493A1 HK 1173493 A1 HK1173493 A1 HK 1173493A1 HK 13100603 A HK13100603 A HK 13100603A HK 1173493 A1 HK1173493 A1 HK 1173493A1
Authority
HK
Hong Kong
Prior art keywords
partially processed
neurotoxin polypeptide
processed neurotoxin
unprocessed
determining
Prior art date
Application number
HK13100603.4A
Other languages
English (en)
Chinese (zh)
Inventor
Harold V Taylor
Karl-Heinz Eisele
Cornelia Brnn
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41466928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1173493(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of HK1173493A1 publication Critical patent/HK1173493A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96402—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
    • G01N2333/96405—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
    • G01N2333/96408—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
    • G01N2333/96419—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
HK13100603.4A 2009-10-21 2013-01-15 System for determining unprocessed nd partially processed neurotoxin polypeptide HK1173493A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27945309P 2009-10-21 2009-10-21
EP09173612 2009-10-21
PCT/EP2010/065618 WO2011048044A1 (en) 2009-10-21 2010-10-18 System for determining unprocessed and partially processed neurotoxin type a

Publications (1)

Publication Number Publication Date
HK1173493A1 true HK1173493A1 (en) 2013-05-16

Family

ID=41466928

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13100603.4A HK1173493A1 (en) 2009-10-21 2013-01-15 System for determining unprocessed nd partially processed neurotoxin polypeptide

Country Status (16)

Country Link
US (2) US8841080B2 (ko)
EP (1) EP2491384B1 (ko)
JP (1) JP5709877B2 (ko)
KR (1) KR101788340B1 (ko)
CN (1) CN102597769B (ko)
AU (1) AU2010309932B2 (ko)
BR (1) BR112012009436A2 (ko)
CA (1) CA2773478C (ko)
ES (1) ES2449303T3 (ko)
HK (1) HK1173493A1 (ko)
IL (1) IL218455A (ko)
IN (1) IN2012DN01954A (ko)
MX (1) MX2012004454A (ko)
PT (1) PT2491384E (ko)
RU (1) RU2545825C9 (ko)
WO (1) WO2011048044A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2479515T3 (es) 2004-07-26 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Composición terapéutica con una neurotoxina botulínica
RU2549463C1 (ru) * 2013-12-03 2015-04-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ определения ботулинического нейротоксина типа а на основе иммунодетекции, сопряженной с полимеразной цепной реакцией

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2340299A (en) * 1998-01-26 1999-08-09 University Of Massachusetts Biologically active hemagglutinin from type a (clostridium botulinum) and methods of use
US6667158B1 (en) * 1998-12-17 2003-12-23 The United States Of America As Represented By The Secretary Of The Army Antibodies against type a botulinum neurotoxin
AU783450B2 (en) 1999-05-12 2005-10-27 United States Army Medical Research Materiel Command (Usamrmc) Recombinant vaccine against botulinum neurotoxin
US20080171347A1 (en) * 2003-04-11 2008-07-17 Atassi M Zouhair Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
CN100575363C (zh) * 2007-03-07 2009-12-30 中国人民解放军军事医学科学院微生物流行病研究所 人源抗a型肉毒神经毒素基因工程抗体及其制备方法与用途
WO2008157374A1 (en) 2007-06-13 2008-12-24 The United States Of America, As Represented By The Secretrary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type a
BRPI1008885B1 (pt) * 2009-02-19 2021-09-28 Merz Pharma Gmbh & Co. Kgaa Método para obter uma solução purificada de polipeptídeos de neurotoxina processados e composição
CN101503472B (zh) * 2009-03-17 2011-08-10 中国人民解放军军事医学科学院生物工程研究所 抗a型肉毒毒素的人源性中和抗体及其应用

Also Published As

Publication number Publication date
ES2449303T3 (es) 2014-03-19
MX2012004454A (es) 2012-05-22
AU2010309932A1 (en) 2012-04-05
CN102597769B (zh) 2014-11-05
IL218455A0 (en) 2012-04-30
US20140349322A1 (en) 2014-11-27
EP2491384A1 (en) 2012-08-29
RU2545825C2 (ru) 2015-04-10
KR101788340B1 (ko) 2017-10-19
BR112012009436A2 (pt) 2017-02-21
WO2011048044A1 (en) 2011-04-28
CA2773478C (en) 2018-07-17
IN2012DN01954A (ko) 2015-08-21
EP2491384B1 (en) 2013-12-04
CN102597769A (zh) 2012-07-18
JP2013508701A (ja) 2013-03-07
US8841080B2 (en) 2014-09-23
IL218455A (en) 2015-10-29
RU2012120572A (ru) 2013-11-27
RU2545825C9 (ru) 2015-06-20
KR20120102639A (ko) 2012-09-18
JP5709877B2 (ja) 2015-04-30
AU2010309932B2 (en) 2015-04-16
CA2773478A1 (en) 2011-04-28
US20120214182A1 (en) 2012-08-23
US9213026B2 (en) 2015-12-15
PT2491384E (pt) 2014-02-21

Similar Documents

Publication Publication Date Title
HK1247629A1 (zh) 用於獲得肉毒桿菌神經毒素的方法和系統
SG10201503705UA (en) Structured Peptide Processing
GB0906698D0 (en) Method for quantifying modified peptides
GB2481099B (en) Tile rendering for image processing
EP2430766A4 (en) IMAGE PROCESSING METHOD FOR MOBILE TERMINAL
ZA201109440B (en) System for gas processing
PL2522724T3 (pl) Sposób modyfikowania polipetydów do oczyszczania multimerów polipeptydowych
GB0911099D0 (en) Processing method
EP2424154A4 (en) Encryption processing system
EP2613857A4 (en) PROCESS FOR PURIFYING IMMUNOCONJUGATES OR ACTIVE POLYPEPTIDES
EP2460354A4 (en) SYSTEM AND METHOD FOR IMPROVING VIDEO QUALITY
EP2338112A4 (en) BATCH PROCESSING SYSTEM
EP2313434A4 (en) NEUTRALIZING ANTIBODIES OF BOTULINIC NEUROTOXINS
IL215234A0 (en) Method for purifying recombinant fsh
PL2381884T3 (pl) Układy do obróbki czwartego palca stopy
BRPI1013965A2 (pt) sistema de moagem e método de moagem.
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
EP2455751A4 (en) METHOD FOR QUANTIFYING PROTEIN
SI2462237T1 (sl) Postopki za izboljšanje ekspresije rekombinantnega proteina
IL216674A0 (en) Enzymatic antibody processing
GB0920783D0 (en) Sample processing system
HK1173493A1 (en) System for determining unprocessed nd partially processed neurotoxin polypeptide
GB201016746D0 (en) Lapping system
EP2484983A4 (en) OPERATING PROCESS FOR A MICRO HEATING SYSTEM
HK1211954A1 (en) Method and system for polypeptide purification